D
Dyne Therapeutics, Inc. DYN
$12.70 $0.746.19% NASDAQ
Recommendation
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
--
52-Week Range
P/E (TTM)
--
EPS (TTM)

03/31/2025 12/31/2024 09/30/2024 06/30/2024 03/31/2024
Revenue -- -- -- -- --
Total Other Revenue -- -- -- -- --
Total Revenue -- -- -- -- --
Cost of Revenue -- -- -- -- --
Gross Profit -- -- -- -- --
SG&A Expenses 15.93M 15.30M 12.86M 9.70M 24.62M
Depreciation & Amortization -- -- -- -- --
Other Operating Expenses -- -- -- -- --
Total Operating Expenses 122.37M 97.11M 105.66M 71.96M 69.16M
Operating Income -122.37M -97.11M -105.66M -71.96M -69.16M
Income Before Tax -115.36M -89.54M -97.13M -65.10M -65.65M
Income Tax Expenses -- -- -- -- --
Earnings from Continuing Operations -115.36M -89.54M -97.13M -65.10M -65.65M
Earnings from Discontinued Operations -- -- -- -- --
Extraordinary Item & Accounting Change -- -- -- -- --
Minority Interest in Earnings -- -- -- -- --
Net Income -115.36M -89.54M -97.13M -65.10M -65.65M
EBIT -122.37M -97.11M -105.66M -71.96M -69.16M
EBITDA -121.87M -96.66M -105.22M -71.56M -68.77M
EPS Basic -1.05 -0.88 -0.96 -0.70 -0.81
Normalized Basic EPS -0.66 -0.55 -0.60 -0.44 -0.51
EPS Diluted -1.05 -0.88 -0.96 -0.70 -0.81
Normalized Diluted EPS -0.66 -0.55 -0.60 -0.44 -0.51
Average Basic Shares Outstanding 109.91M 101.98M 100.88M 92.51M 81.04M
Average Diluted Shares Outstanding 109.91M 101.98M 100.88M 92.51M 81.04M
Dividend Per Share -- -- -- -- --
Payout Ratio -- -- -- -- --